Therapy of Hepatitis B and Prevention of Hepatocellular Carcinoma
Major advances have been made in the past two decades in the therapy of chronic hepatitis B. However, it is not clear whether these are truly “milestones” in our laborious quest to control HBV infection and to overcome this immense disease burden. The goals for therapy for chronic hepatitis B have been well defined: 1. Eradication of HBV from the host. 2. Resolution of inflammatory in the liver. 3. Prevent fibrosis and cirrhosis. 4. Prevention of HCC. 5. Restore survival and quality of life
In addressing these issues on therapy and prevention of HCC, one has to recognize a few important facts regarding CHB and HCC in Asian countries those are not seen in other parts of the world.
KeywordsChronic Hepatitis HBeAg Seroconversion Sustained Viral Response Lamivudine Therapy Lamivudine Treatment
Unable to display preview. Download preview PDF.
- 2.Liaw YF, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, Chien RN, Dent J, Roman L, Edmundson S, Lai CL. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. Gastroenterology 2000; 199: 172–80.Google Scholar
- 3.Leung NW, Lai CL, Chang TT, Guan R, Lee CM, Ng KY, Lim SG, Wu PC, Dent JC, Edmundson S, Condreay LD, Chien RN. Extended lamivudine treatment in patients 83 with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology 2001; 33: 1527–32.PubMedCrossRefGoogle Scholar